Skip to main content

Rhenman & Partners Asset Management AB

Position in ABBV — AbbVie Inc.

CIK 1599882 Stockholm, V7

Position in ABBV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$24,352,461
+$8,785,615 QoQ
Shares Held
96,775
+35.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.30%
of 13F equity value
Holder Rank
#546
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. ABBV ranks #4 (14.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ABBV
AbbVie Inc.
This page
96,775 $24,352,461

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,352,461 96,775
2026-03-31 $15,566,846 71,575
2025-12-31 $25,265,281 110,575
2025-09-30 $30,187,027 130,375
2025-06-30 $12,877,387 69,375
2025-03-31 $18,573,948 88,650
2024-12-31 $22,061,455 124,150
2024-09-30 $34,953,960 177,000
2024-06-30 $32,417,280 189,000
2024-03-31 $34,507,950 189,500
2023-12-31 $25,879,990 167,000
2023-09-30 $22,359,000 150,000
2023-06-30 $20,209,500 150,000
2023-03-31 $24,224,240 152,000
2022-12-31 $21,009,300 130,000
2022-09-30 $20,081,305 149,626
2022-06-30 $29,100,400 190,000
2022-03-31 $31,611,450 195,000
2021-12-31 $45,359,000 335,000
2021-09-30 $38,293,850 355,000
2021-06-30 $36,044,800 320,000
2021-03-31 $39,824,960 368,000
2020-12-31 $53,575,000 500,000
2020-09-30 $24,525,200 280,000
2020-06-30 $29,454,000 300,000
2020-03-31 $25,142,700 330,000